1don MSN
Elironrasib may overcome resistance to prior KRAS G12C inhibition in non-small cell lung cancer
Elironrasib led to meaningful and durable responses in patients with metastatic KRAS G12C-mutated non-small cell lung cancer ...
Ibtrozi is a medicine called a kinase inhibitor that is used to treat a certain type of lung cancer called non-small-cell lung cancer (NSCLC) that is caused by an abnormal ROS1 gene. NSCLC is the most ...
Background Compared with cytotoxic chemotherapy, the efficacy and safety of immune checkpoint inhibitors (ICIs) for patients ...
In recent research, treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback